Logo (USPTO, 05/21/2004)
USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark was filed as Figurative mark on 05/21/2004 at the U.S. Patent and Trademark Office. The current status of the mark is "ABANDONED - NO STATEMENT OF USE FILED".
| Trademark form | Figurative mark |
| File reference | 78423268 |
| Application date | May 21, 2004 |
| Publication date | November 1, 2005 |
Trademark owner
4840 Pearl East Circle
80301 Boulder
US
80301 Boulder
US
Trademark representatives
goods and services
1
Chemicals for use in science and in pharmaceutical manufacture; chemical preparations, namely carriers and excipients in the nature of chemical additives for use in the manufacture of pharmaceuticals
5
Pharmaceutical substances and preparations, namely, anticancer agents; genetic substances for use in treatment of neurodegenerative diseases; chemical preparations, namely carriers and excipients in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; diagnostic reagents and pharmaceutically active agents for medical research use for treatment of cancer and neurodegenerative disorders
40
Custom manufacturing services for the preparation of pharmaceuticals and pharmaceutically active materials; processing of pharmaceuticals and pharmaceutically active materials; extraction of chemical substances from plant materials and purification of the crude plant extract; treatment of plant materials for use in research and development and in pharmaceutical manufacture
42
Scientific research comprising medical and genetic analysis and investigation of clinical trial recruits for the benefit of pharmaceutical companies; licensing of patents and intellectual property; chemical analysis; scientific and medical research; research services relating to the development and testing of pharmaceuticals; scientific research relating to genetics and oncology; development and licensing of anticancer agents; developing cures for cancer and hereditary disease and diseases involving cellular dysfunction other than cancer and hereditary diseases.
ID: 1378423268